| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/17/1998 | WO1998040484A1 Intracellular amyloid-beta binding (erab) polypeptide |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040469A1 Haemocompatible surfaces |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040098A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | WO1998030680A3 Special catalytic domains of CDC25C phosphatase |
| 09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/17/1998 | WO1998026046A3 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 09/17/1998 | DE19710496A1 Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen A method for detecting antigen-specific T cells after enrichment of mononuclear cell populations |
| 09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284514A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | CA2284137A1 Prostate specific antigen substrates |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283293A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 09/17/1998 | CA2280997A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/17/1998 | CA2232119A1 Use of a strain of pasteurella haemolytica serotype a6 for the preparation of a vaccine against bovine pneumonic pasteurellosis due to pasteurella haemolytica |
| 09/16/1998 | EP0864865A2 Method for measuring glycated hemoglobin |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0864088A1 A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 09/16/1998 | EP0863982A1 Synthetic hpv11 virus-like particles |
| 09/16/1998 | EP0620854B1 Expression and purification of recombinant soluble tissue factor |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | EP0541556B1 Stabilization of biological macromolecular substances and other organic compounds |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | EP0485430B1 Methods and compositions for ameliorating the symptoms of sepsis |
| 09/16/1998 | CN1193353A Allergen-XCD32 fusion proteins |
| 09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
| 09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/15/1998 | US5808079 Imidazolinone haptens |
| 09/15/1998 | US5808033 Family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/15/1998 | US5808032 Anti-HBS antibody genes and expression plasmids therefor |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808025 Polypeptide |
| 09/15/1998 | US5808009 Method of affinity purifying antibodies |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808005 Medical diagnosis; vaccines |
| 09/15/1998 | US5808004 Fragments of a lymphocyte adhesion receptor for high endothelium, CD44 |
| 09/15/1998 | US5808002 Stem cell factor receptor-(c-kit)-specific monoclonal antibody A3C6E2 |
| 09/15/1998 | US5808001 Human ice homolog antibodies and compositions thereof |
| 09/15/1998 | US5808000 Virus-safe monomeric human immunoglobulin A and methods for its production |
| 09/15/1998 | US5807999 Analyzing |
| 09/15/1998 | US5807997 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 09/15/1998 | US5807996 Fused polypeptides comprising interleukin-4 polypeptide fragments |
| 09/15/1998 | US5807995 Diagnosis and treatment of cancer |
| 09/15/1998 | US5807992 Vaccines; medical diagnosis |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807978 Polypeptide with hydrophilic and hydrophobic regions; cancer diagnosis |
| 09/15/1998 | US5807879 Biotinidase-resistant biotinylated compound and methods of use thereof |
| 09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807745 Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component |
| 09/15/1998 | US5807741 Neutralizing monoclonal antibody against botulinum neurotoxin serotype F |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807715 Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| 09/15/1998 | US5807712 Genetic engineered protein |
| 09/15/1998 | US5807706 Genetic engineering |
| 09/15/1998 | US5807705 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, DNA encoding same and uses thereof |
| 09/15/1998 | US5807698 Human cyclin E |
| 09/15/1998 | US5807695 Metallic cation binding polypeptides and methods therefor |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/15/1998 | US5807551 Method to provide artificial passive immunity in birds |
| 09/15/1998 | US5807550 Antibodies specifically recognizing somatotropin binding proteins |
| 09/15/1998 | US5807549 Lymphocyte chemoattractant factor and uses thereof |
| 09/15/1998 | US5807548 Method of treating cancer using a chimera antibody |
| 09/15/1998 | CA2106080C Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | WO1998039440A2 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF |
| 09/11/1998 | WO1998039439A1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 09/11/1998 | WO1998039434A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/11/1998 | WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | WO1998039429A2 Compositions for treatment of disorders involving programmed cell death |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | WO1998039424A1 Dna encoding pneumocystis carinii protease |
| 09/11/1998 | WO1998039363A2 Immunotoxins and methods of inducing immune tolerance |
| 09/11/1998 | WO1998039362A1 Cytotoxic immunoglobulins from mammals |
| 09/11/1998 | WO1998039361A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | WO1998039360A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 09/11/1998 | WO1998039356A1 Purified and recombinant antigenic proteins associated with abdominal aortic aneurysm (aaa) disease |
| 09/11/1998 | WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998039027A2 Sialyl lewis antigens as targets for immunotherapy |